These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11252338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin].
    Husson MO, Fruchart A, Izard D.
    Pathol Biol (Paris); 1998 Apr; 46(4):279-83. PubMed ID: 9769909
    [Abstract] [Full Text] [Related]

  • 4. Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.
    Lai CC, Chen CC, Chuang YC, Tang HJ.
    Sci Rep; 2017 Jan 31; 7():41758. PubMed ID: 28139739
    [Abstract] [Full Text] [Related]

  • 5. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M, Boutros N, Raymond J.
    Int J Antimicrob Agents; 2004 Mar 31; 23(3):247-53. PubMed ID: 15164965
    [Abstract] [Full Text] [Related]

  • 6. In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
    Raymond J, Vedel G, Bergeret M.
    Diagn Microbiol Infect Dis; 1998 Jul 31; 31(3):481-3. PubMed ID: 9635241
    [No Abstract] [Full Text] [Related]

  • 7. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M.
    J Chemother; 2003 Jun 31; 15(3):239-43. PubMed ID: 12868549
    [Abstract] [Full Text] [Related]

  • 8. [Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
    Hasegawa H, Kanai A, Otoguro K, Shimizu K.
    Kansenshogaku Zasshi; 1996 Feb 31; 70(2):151-60. PubMed ID: 8851387
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G, Isert D, Klesel N, Limbert M, Markus A, Schrinner E.
    J Antimicrob Chemother; 1992 Apr 31; 29 Suppl A():25-30. PubMed ID: 1601753
    [Abstract] [Full Text] [Related]

  • 10. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M, Asari S, Nishi I, Horikawa M, Tsukamoto H, Sunada A, Ueda A, Iwatani Y.
    J Chemother; 2003 Feb 31; 15(1):31-6. PubMed ID: 12678411
    [Abstract] [Full Text] [Related]

  • 11. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec 31; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E, Falcone M, Baiocchi P, Pompeo ME, Pierciaccante A, Penni A, Venditti M.
    Infez Med; 2005 Jun 31; 13(2):97-102. PubMed ID: 16220029
    [Abstract] [Full Text] [Related]

  • 13. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A, Lion C, Mory F, Weber M.
    J Antimicrob Chemother; 2001 Jan 31; 47(1):83-6. PubMed ID: 11152435
    [Abstract] [Full Text] [Related]

  • 14. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Aug 31; 24(4):187-90. PubMed ID: 23040680
    [Abstract] [Full Text] [Related]

  • 15. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R, Raad I.
    Eur J Clin Microbiol Infect Dis; 1996 Dec 31; 15(12):933-6. PubMed ID: 9031876
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Sep 31; 40(9):1973-6. PubMed ID: 8878565
    [Abstract] [Full Text] [Related]

  • 18. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
    Roussel-Delvallez M, Wallet F, Barbiery P, Courcol RJ.
    J Chemother; 1997 Feb 31; 9(1):5-8. PubMed ID: 9106011
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.